BioExtraction Overview
- Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$399K
- Investors
-
2
BioExtraction General Information
Description
Manufacture of pharmaceutical products intended to offer contract service for chemical extraction. The company's product develops isolation and separation strategies for natural products, peptides, and large synthetic molecules across the whole range of polarity, enabling pharmaceutical and chemical industries to isolate and extract multiple target compounds in a single pass and making the process both cost and time effective.
Contact Information
Website
www.bioextractions.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Industrial Chemicals
Other Industries
Pharmaceuticals
Other Commercial Services
Primary Office
- Unit 30 Tafarnaubach Industrial Estate
- Tafarnaubach Blaenau Gwent
- Tredegar NP22 3AA
- Wales, United Kingdom
+44 01495 000000
BioExtraction Timeline
BioExtraction Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Angel (individual) | 31-Dec-2021 | $399K | 00.000 | 00.000 | Completed | Generating Revenue |
| 5. Grant | 01-Aug-2020 | 00000 | 00.000 | Completed | Generating Revenue | |
| 4. Grant | 01-Sep-2017 | 0000 | 00.000 | Completed | Generating Revenue | |
| 3. Grant | 01-Aug-2017 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Early Stage VC | 31-Oct-2015 | $788K | $1.04M | 00.000 | Completed | Generating Revenue |
| 1. Early Stage VC | 28-Jan-2014 | $247K | $247K | 00.000 | Completed | Generating Revenue |
BioExtraction Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary A | 00,000 | 00.000000 | 000.0 | 000.0 | 00 | 000.0 | 00.000 | |
| Ordinary A | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
BioExtraction Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Kevin Napier | Chief Operating Officer | ||
| Aled Finniear | Chief Scientific Officer |
BioExtraction Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| John Jenkins | BioExtraction | Board Member | 000 0000 |
| Kevin Stephens | BioExtraction | Board Member | 000 0000 |
| Roger Jones | BioExtraction | Board Member | 000 0000 |
BioExtraction Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Innovate UK | Government | 000 0000 | 000000 0 | ||
| Mercia Asset Management | Growth/Expansion | Minority | 000 0000 | 000000 0 |